Diffuse endoscopically visible, predominantly low grade dysplasia in Barrett’s esophagus (with video)

Abstract

Background Low grade dysplasia (LGD) in Barrett’s esophagus (BE) has generally been considered as undetectable endoscopically.

Aim To describe a phenotype which consists of diffuse, endoscopically visible, predominantly low grade dysplasia in Barrett’s esophagus (DEVLB), with often subtle but visible endoscopic changes seen with high definition white light (HDWL) and narrow-band imaging (NBI).

Method A systematic search of a prospectively collected database for patients satisfying predefined criteria for DEVLB and a review of endoscopic and histological features of biopsies and endoscopic mucosal resection (EMR) specimens.

Results Out of a total of 419 patients referred to our expert center for assessment of dysplastic Barrett’s esophagus during the period January 2009 to March 2018, there were 7 patients (1.7 %) who satisfied the criteria defined for DEVLB, identified on their initial assessment endoscopy. All patients were treated by EMR of visible abnormal mucosa during their assessment endoscopy at our tertiary referral center. There was a total of 47 EMR specimens obtained, with a median of 6 (IQR 5–9) EMR resection pieces per patient, of which 36 (77 %) contained LGD, 8 (17 %) high grade dysplasia (HGD), 2 (4 %) non-dysplastic Barrett’s esophagus (NDBE), and 1 (2 %) contained early esophageal adenocarcinoma (EAC).

Conclusion DEVLB is a distinct phenotype seen in a small but significant proportion of individuals with dysplastic Barrett’s esophagus. Patients with DEVLB have widespread LGD, with many having areas of focal HGD or early cancer within this area. We believe these patients are best treated with extensive EMR of the visibly abnormal area.

• References

• 1 Singh R, Jayanna M, Wong J. et al. Narrow-band imaging and white-light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett’s esophagus: results of the Asia-Pacific Barrett’s Consortium. Endosc Int Open 2014; 03: E14-E18
• 2 Jayasekera C, Taylor ACF, Desmond PV. et al. Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett’s esophagus neoplasia. Endoscopy 2012; 44: 1089-1095
• 3 Song J, Zhang J, Wang J. et al. Meta-analysis of the effects of endoscopy with narrow band imaging in detecting dysplasia in Barrett’s esophagus. Dis Esophagus 2015; 28: 560-566
• 4 Beg S, Mensa M, Fullard M. et al. Impact of advanced endoscopic imaging on Barrett’s esophagus in daily clinical practice. Gastrointest Endosc 2018; 87: 1189-1194
• 5 Curvers WL, Ten Kate FJ, Krishnadath KK. et al. Low-grade dysplasia in Barrett’s esophagus: Overdiagnosed and underestimated. Am J Gastroenterol 2010; 105: 1523-1530
• 6 Wani S, Rubenstein JH, Vieth M. et al. Diagnosis and management of low-grade dysplasia in Barrett’s esophagus: Expert review from the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology 2016; 151: 822-835
• 7 Wani S, Falk GW, Post J. et al. Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology 2011; 141: 1179-1186, 1186.e1
• 8 Vennalaganti P, Kanakadandi V, Goldblum JR. et al. Discordance among pathologists in the United States and Europe in diagnosis of low-grade dysplasia for patients with Barrett’s esophagus. Gastroenterology 2017; 152: 564-570.e4
• 9 Duits LC, van der Wel MJ, Cotton CC. et al. Patients with Barrett’s esophagus and confirmed persistent low-grade dysplasia are at increased risk for progression to neoplasia. Gastroenterology 2017; 152: 993-1001.e1
• 10 Srivastava A, Hornick JL, Li X. et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett’s esophagus. Am J Gastroenterol 2007; 102: 483-493, quiz 694
• 11 Reid BJ, Prevo LJ, Galipeau PC. et al. p53 and neoplastic progression in Barrett’s esophagus. Am J Gastroenterol 2001; 96: 2839-2848
• 12 Kestens C, Offerhaus GJA, Baal JWPMv. et al. Patients with Barrett’s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol 2016; 14: 956-962.e951
• 13 Kariyawasam VC, Bourke MJ, Hourigan LF. et al. Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett’s esophagus. Gastrointest Endosc 2012; 75: 938-944
• 14 Pech O, Gossner L, Manner H. et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy 2007; 39: 588-593
• 15 Cassani L, Sumner E, Slaughter JC. et al. Directional distribution of neoplasia in Barrett’s esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc 2013; 77: 877-882
• 16 Omae M, Fujisaki J, Shimizu T. et al. Correlation of the location of superficial Barrett’s esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux. Endosc Int Open 2016; 04: E515-E520